Expertise: MedTech 36 results

MedTech

Using the 505(b)(2) Pathway to Streamline Regulatory Approval for Combination Products

In recent years, the number of approvals for combination products and 505(b)(2) applications has been rising. Combination products consist of at least two constituent parts, each subject to its own statutory and regulatory requirements. Unlike fixed-dose combination therapies, which consist of drug-drug combinations, combination products can include any of the following: The U.S. Food and…